PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 949642

Gastrointestinal hormones.

S N Sullivan
View original source ↗Export metadata ↓

Abstract

The availability of pure intestinal hormones and the development of radioimmunoassays for their measurement has expedited research into many aspects of gastrointestinal endocrinology. A complex balance evidently exists between the different intestinal hormones and also the rest of the endocrine system. Polyendocrinopathies have been described, and, so far, two diseases due to intestinal hormone excess (Zollinger-Ellison syndrome and the syndrome of watery diarrhea, hypokalemia and achlorhydria) elucidated. It seems likely that many more gastrointestinal endocrine diseases await discovery.

Explore related subjects

CholecystokininDiagnosis, DifferentialDiarrheaDigestive SystemEndocrine GlandsEsophagogastric JunctionGastrinsGastrointestinal HormonesHumansHypoglycemiaIntestinal DiseasesIntestine, LargePancreasPeptic UlcerProstaglandinsPylorusSecretinSyndromeZollinger-Ellison SyndromeJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S N Sullivan. 1976. Gastrointestinal hormones.. https://pubmed.ncbi.nlm.nih.gov/949642/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Role of cholecystokinin and central serotonergic receptors in functional dyspepsia.

Symptoms of functional dyspepsia are characterized by upper abdominal discomfort or pain, early satiety, postprandial fullness,bloating, nausea and vomiting. It is a chronic disorder, with symptoms more than 3 mo per year,and no evidence of organic diseases. Dysfunctional motility, altered visceral sensation, and psychosocial factors have all been identified as major pathophysiological mechanisms. It is believed that these pathophysiological mechanisms interact to produce the observed symptoms. Dyspepsia has been categorized into three subgroups based on dominant symptoms. Dysmotility-like dyspepsia describes a subgroup of patients whose symptom complex is usually related to a gastric sensorimotor dysfunction. The brain-gut peptide cholecystokinin (CCK) and serotonin (5-HT) share certain physiological effects. Both have been shown to decrease gastric emptying and affect satiety. Furthermore the CCK induced anorexia depended on serotonergic functions probably acting via central pathways. We believe that abnormalities of central serotonergic receptors functioning together with a hyper responsiveness to CCK or their interactions may be responsible for the genesis of symptoms in functional dyspepsia (FD).

Cholecystokinin↗